Most state Medicaid programs don’t cover the new class of weight loss drugs for obesity ... While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common ...

Medicines affecting the GLP-1 receptor are in vogue for weight loss right now. Zealand Pharma has GLP-1 candidates, but also a compelling alternative approach. BioAge Labs' lead program could ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Glucagon-like peptide medications that treat Type 2 diabetes and weight management continue to grow in popularity, though ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Perrigo intends to put focus at select retailers on over-the-counter medications that relieve the side effects of GLP-1 drugs ...

Drug developer Endevica Bio is spinning off a new company, Abisati, to focus solely on one promising weight-loss treatment. Northbrook-based Endevica has found its peptide drug candidate 710GO, an ...

Prescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled ... hospital-based metabolic bariatric surgery programs due to decreased demand," they noted in the ...

Maryland’s policymakers should expand Medicaid coverage to include weight loss medications, writes Michelle Rogers.

So, if you're looking for exposure to the growth of the weight loss market but are loath ... making it highly differentiated from GLP-1 drugs. That program will soon enter phase 2b clinical ...